Pay in 4 interest-free payments of $7.37 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Figure 1: A metabolic use-case comprehensive patient journey view with taXonomy Pathways In clinical trials, GLP-1 drugs showed high adherence (over 85% of patients stayed on therapy), yet real-world use tells a different story: one large study found only 32% of obese patients remained on a GLP-1 therapy after one year, with just 27% meeting standard adherence thresholds
The feedback across platforms varies enough in tone and specificity to appear authentic, with no obvious patterns of amplification or fake reviews
Mondelez International, which produces packaged food products, has seen its stock price fall as comments from Walmart indicated that individuals taking GLP-1 drugs have reduced the amount of food they purchase
E.FernandesT
US$ 28.48
US$ 28.91
US$ 28.08
